Horizon Med Tech Limited 15872191 false 2024-08-02 2025-08-31 2025-08-31 The principal activity of the company is retail sale of medical goods Digita Accounts Production Advanced 6.30.9574.0 true true 15872191 2024-08-02 2025-08-31 15872191 2025-08-31 15872191 core:CurrentFinancialInstruments 2025-08-31 15872191 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 15872191 bus:SmallEntities 2024-08-02 2025-08-31 15872191 bus:AuditExemptWithAccountantsReport 2024-08-02 2025-08-31 15872191 bus:FilletedAccounts 2024-08-02 2025-08-31 15872191 bus:SmallCompaniesRegimeForAccounts 2024-08-02 2025-08-31 15872191 bus:RegisteredOffice 2024-08-02 2025-08-31 15872191 bus:Director1 2024-08-02 2025-08-31 15872191 bus:Director2 2024-08-02 2025-08-31 15872191 bus:PrivateLimitedCompanyLtd 2024-08-02 2025-08-31 15872191 countries:UnitedKingdom 2024-08-02 2025-08-31 iso4217:GBP xbrli:pure

Registration number: 15872191

Horizon Med Tech Limited

Unaudited Filleted Financial Statements

for the Period from 2 August 2024 to 31 August 2025

 

Horizon Med Tech Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 3

 

Horizon Med Tech Limited

(Registration number: 15872191)
Balance Sheet as at 31 August 2025

Note

2025
£

Current assets

 

Debtors

4

4,403

Cash at bank and in hand

 

16,290

 

20,693

Creditors: Amounts falling due within one year

5

(33,080)

Net liabilities

 

(12,387)

Capital and reserves

 

Called up share capital

2

Retained earnings

(12,389)

Shareholders' deficit

 

(12,387)

For the financial period ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 16 January 2026 and signed on its behalf by:
 

Mr T Foster
Director

Dr P R Reynolds
Director

 
     
 

Horizon Med Tech Limited

Notes to the Unaudited Financial Statements for the Period from 2 August 2024 to 31 August 2025

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Parkhill Studio
Walton Road
Wetherby
West Yorkshire
LS22 5DZ
United Kingdom

These financial statements were authorised for issue by the Board on 16 January 2026.

2

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

 

Horizon Med Tech Limited

Notes to the Unaudited Financial Statements for the Period from 2 August 2024 to 31 August 2025

4

Debtors

Current

2025
£

Prepayments

3,142

Other debtors

1,261

 

4,403

5

Creditors

Creditors: amounts falling due within one year

Note

2025
£

Due within one year

 

Loans and borrowings

6

22,007

Accruals and deferred income

 

600

Other creditors

 

10,473

 

33,080

6

Loans and borrowings

Current loans and borrowings

2025
£

Other borrowings

22,007